193 related articles for article (PubMed ID: 8881132)
1. Thromboembolic prophylaxis in orthopaedic trauma patients: a comparison between a fixed dose and an individually adjusted dose of a low molecular weight heparin (nadroparin calcium).
Haentjens P
Injury; 1996 Jul; 27(6):385-90. PubMed ID: 8881132
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety of weight-adapted nadroparin calcium vs. heparin sodium in prevention of clinically evident thromboembolic complications in 1,190 general surgical patients.
Egger B; Schmid SW; Naef M; Wildi S; Büchler MW
Dig Surg; 2000; 17(6):602-609. PubMed ID: 11155006
[TBL] [Abstract][Full Text] [Related]
3. A fixed-dose combination of low molecular weight heparin with dihydroergotamine versus adjusted-dose unfractionated heparin in the prevention of deep-vein thrombosis after total hip replacement.
Horbach T; Wolf H; Michaelis HC; Wagner W; Hoffmann A; Schmidt A; Beck H
Thromb Haemost; 1996 Feb; 75(2):246-50. PubMed ID: 8815569
[TBL] [Abstract][Full Text] [Related]
4. Nadroparin calcium. A review of its pharmacology and clinical use in the prevention and treatment of thromboembolic disorders.
Davis R; Faulds D
Drugs Aging; 1997 Apr; 10(4):299-322. PubMed ID: 9108990
[TBL] [Abstract][Full Text] [Related]
5. [Prevention of venous thromboembolism in polytraumatized patients. Epidemiology and importance].
Venet C; Berger C; Tardy B; Viallon A; Decousus H; Bertrand JC
Presse Med; 2000 Jan; 29(2):68-75. PubMed ID: 10682030
[TBL] [Abstract][Full Text] [Related]
6. Home therapy with LMWH in deep vein thrombosis: randomized study comparing single and double daily administrations.
Bellosta R; Ferrari P; Luzzani L; Carugati C; Cossu L; Talarico M; Sarcina A
Angiology; 2007; 58(3):316-22. PubMed ID: 17626986
[TBL] [Abstract][Full Text] [Related]
7. Low molecular weight heparin versus acenocoumarol in the secondary prophylaxis of deep vein thrombosis.
Lopaciuk S; Bielska-Falda H; Noszczyk W; Bielawiec M; Witkiewicz W; Filipecki S; Michalak J; Ciesielski L; Mackiewicz Z; Czestochowska E; Zawilska K; Cencora A
Thromb Haemost; 1999 Jan; 81(1):26-31. PubMed ID: 9974369
[TBL] [Abstract][Full Text] [Related]
8. Anticoagulant therapy for symptomatic calf deep vein thrombosis (CACTUS): a randomised, double-blind, placebo-controlled trial.
Righini M; Galanaud JP; Guenneguez H; Brisot D; Diard A; Faisse P; Barrellier MT; Hamel-Desnos C; Jurus C; Pichot O; Martin M; Mazzolai L; Choquenet C; Accassat S; Robert-Ebadi H; Carrier M; Le Gal G; Mermilllod B; Laroche JP; Bounameaux H; Perrier A; Kahn SR; Quere I
Lancet Haematol; 2016 Dec; 3(12):e556-e562. PubMed ID: 27836513
[TBL] [Abstract][Full Text] [Related]
9. [Determination of factor Xa inhibition doses of low-molecular heparin, nadroparin and reviparin in urological patients].
Pavlović S; Zivković S; Koraćević G
Vojnosanit Pregl; 2007 Aug; 64(8):538-42. PubMed ID: 17874721
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of prevention of thromboembolic complications with LMW-heparin in experiment.
Szücs G; Mikó I; Ajzner E; Póti L; Szepesi K; Furka I
Acta Chir Hung; 1997; 36(1-4):356-8. PubMed ID: 9408400
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of deep venous thrombosis prophylaxis in trauma patients and identification of high-risk groups.
Dennis JW; Menawat S; Von Thron J; Fallon WF; Vinsant GO; Laneve LM; Jagger C; Frykberg ER
J Trauma; 1993 Jul; 35(1):132-8; discussion 138-9. PubMed ID: 8331703
[TBL] [Abstract][Full Text] [Related]
12. Prevention of deep vein thrombosis with low molecular-weight heparin in patients undergoing total hip replacement. A randomized trial. The German Hip Arthroplasty Trial (GHAT) Group.
Arch Orthop Trauma Surg; 1992; 111(2):110-20. PubMed ID: 1314065
[TBL] [Abstract][Full Text] [Related]
13. Nadroparin or fondaparinux versus no thromboprophylaxis in patients immobilised in a below-knee plaster cast (PROTECT): A randomised controlled trial.
Bruntink MM; Groutars YME; Schipper IB; Breederveld RS; Tuinebreijer WE; Derksen RJ;
Injury; 2017 Apr; 48(4):936-940. PubMed ID: 28279428
[TBL] [Abstract][Full Text] [Related]
14. [Efficacy and tolerability of fraxiparine in the prevention of thromboembolic complications in oncologic thoracic surgery].
Azorin JF; Regnard JF; Dahan M; Pansart M
Ann Cardiol Angeiol (Paris); 1997; 46(5-6):341-7. PubMed ID: 9295896
[TBL] [Abstract][Full Text] [Related]
15. Comparison of low-molecular-weight heparin, administered primarily at home, with unfractionated heparin, administered in hospital, and subcutaneous heparin, administered at home for deep-vein thrombosis.
Belcaro G; Nicolaides AN; Cesarone MR; Laurora G; De Sanctis MT; Incandela L; Barsotti A; Corsi M; Vasdekis S; Christopoulos D; Lennox A; Malouf M
Angiology; 1999 Oct; 50(10):781-7. PubMed ID: 10535716
[TBL] [Abstract][Full Text] [Related]
16. Prophylaxis against venous thromboembolism in orthopedic surgery.
Liu LT; Ma BT
Chin J Traumatol; 2006 Aug; 9(4):249-56. PubMed ID: 16849000
[TBL] [Abstract][Full Text] [Related]
17. Prophylaxis of thromboembolic disease with RO-11 (ROVI), during abdominal surgery. EMRO1 (Grupo Fstudio Multicintrico RO-11).
Moreno Gonzalez E; Fontcuberta J; de la Llama F
Hepatogastroenterology; 1996; 43(9):744-7. PubMed ID: 8799424
[TBL] [Abstract][Full Text] [Related]
18. Comparison of a low molecular weight heparin and unfractionated heparin for the prevention of deep vein thrombosis in patients undergoing abdominal surgery. The European Fraxiparin Study (EFS) Group.
Br J Surg; 1988 Nov; 75(11):1058-63. PubMed ID: 2905187
[TBL] [Abstract][Full Text] [Related]
19. Comparison of two treatment durations (6 days and 14 days) of a low molecular weight heparin with a 6-day treatment of unfractionated heparin in the initial management of unstable angina or non-Q wave myocardial infarction: FRAX.I.S. (FRAxiparine in Ischaemic Syndrome).
Eur Heart J; 1999 Nov; 20(21):1553-62. PubMed ID: 10529323
[TBL] [Abstract][Full Text] [Related]
20. Prevention of deep-vein thrombosis and pulmonary embolism after total hip replacement. Comparison of low-molecular-weight heparin and unfractionated heparin.
Eriksson BI; Kälebo P; Anthymyr BA; Wadenvik H; Tengborn L; Risberg B
J Bone Joint Surg Am; 1991 Apr; 73(4):484-93. PubMed ID: 2013587
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
